The non-cardiovascular actions of ACE

Peptides. 2022 Jun:152:170769. doi: 10.1016/j.peptides.2022.170769. Epub 2022 Feb 17.

Abstract

Angiotensin converting enzyme (ACE) is well known for its role producing the vasoconstrictor angiotensin II and ACE inhibitors are commonly used for treating hypertension and cardiovascular disease. However, ACE has many different substrates besides angiotensin I and plays a role in many different physiologic processes. Here, we discuss the role of ACE in the immune response. Several studies in mice indicate that increased expression of ACE by macrophages or neutrophils enhances the ability of these cells to respond to immune challenges such as infection, neoplasm, Alzheimer's disease, and atherosclerosis. Increased expression of ACE induces increased oxidative metabolism with an increase in cell content of ATP. In contrast, ACE inhibitors have the opposite effect, and in both humans and mice, administration of ACE inhibitors reduces the ability of neutrophils to kill bacteria. Understanding how ACE affects the immune response may provide a means to increase immunity in a variety of chronic conditions now not treated through immune manipulation.

Keywords: ACE; Angiotensin; Immunity; Macrophages.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Hypertension* / drug therapy
  • Hypertension* / metabolism
  • Macrophages / metabolism
  • Mice
  • Peptidyl-Dipeptidase A* / genetics
  • Peptidyl-Dipeptidase A* / metabolism

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin I
  • Peptidyl-Dipeptidase A